|Day Low/High||108.07 / 109.21|
|52 Wk Low/High||62.55 / 113.41|
Put down the slingshot and study these seven tenets.
Right off the top, the bubble has burst for the 'short squeeze' names such as GameStop and AMC Entertainment.
Four experts highlight their favorite dividend stocks for 2021.
I think investors deserve much better than to say that there's no opportunity for income in this market.
I am talking about themes that can stand the test not of today, or tomorrow, but for all of 2021 and beyond.
It's a stock that underperformed the last two years but would likely excel in a year of renewed growth in economic activity.
I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.
All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
Plus, we check out up the bevy of reasons for this week's negative market behavior.
This is the type of chart that will grab the attention of momentum traders.
AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.
Also, interpreting Tuesday's market, Covid-19 vaccine update, and manufacturing growth.
6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.
There is no thought of selling here and now, even with politicized pressure on the industry.
Plus, it could be quite a while before the labor market can absorb all those people who are out of jobs.
These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.
I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.
Here's an updated strategy for ABBV, which could see new highs soon.
I have always liked the aggressive management.
A lifting on the moratorium on elective procedures could be a big win for ABBV.
What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.
The market sold off on Thursday after close as big hitters, including Amazon, reported earnings.